Spero Therapeutics, Inc. Profile Avatar - Palmy Investing

Spero Therapeutics, Inc.

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product can…

Biotechnology
US, Cambridge [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of SPRO's Analysis
CIK: 1701108 CUSIP: 84833T103 ISIN: US84833T1034 LEI: - UEI: -
Secondary Listings
SPRO has no secondary listings inside our databases.